Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

South San Francisco, CA, USA

Shinobi Therapeutics

F-Prime Capital is a global venture capital firm investing in healthcare and technology, with a heritage that spans four decades.

F-Prime Capital Partners

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining F-Prime Capital Partners Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the F-Prime Capital Partners network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a F-Prime Capital Partners company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.